Alan Lipschitz, M.D. Email & Phone Number

Us

- Led the teams that delivered positive phase 2 cariprazine Bipolar Depression and Major Depression trials. - Led Fetzima and Savella teams: developed strategy for adult and pediatric depression and fibromyalgia, planned and launched phase 3 clinical trials, life cycle, registries.- Managed the clinical evaluation of phase 1 and 2 in-licensing candidate compounds. - Coordinated pediatric trials across Forest Neuroscience compounds.

Lawrence Township, Nj, Us

Managed medical strategy for clinical trial programs in Alzheimer's disease dementia and predementia, Progressive Supranuclear Palsy, and other neurodegenerative disorders

Brentford, Middlesex, Gb

Organized and led clinical development and translational medicine teams planning and conducting clinical trials, developing, differentiating and managing compounds for Neurology and Psychiatry indications.

New York, New York, Us

- Led the medical functions for neuroscience activities: defined and implemented clinical trials and regulatory filings, conducted advisory boards, developed promotional programs, trained faculty, led Medical Science Liaison team, managed thought leader contacts, coordinated extramural studies, marketing, and public relations efforts- Built EffexorXR into Wyeth’s lead product and first billion-dollar franchise, co-chairing the Global Brand Team: managing clinical trials, global regulation and supply, brand extension, and life cycle.- Planned and managed successful EffexorXR trials in PTSD and Primary Care Depression.- Filed sNDA’s for EffexorXR Social Anxiety Disorder, Relapse Prevention; Sonata Extended Efficacy.- Supported Sonata strategic planning, life-cycle management and co-marketing with Elan.- Led Medical team in joint ventures treating insomnia, pain, Alzheimer’s Disease (AN-1792).

Psychiatry Residency Program

Pgy-1, Rotating

Md

Ba, Psychology